Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Anti-Cancer Drugs|May 31, 2018
Dabrafenib and trametinib treatment-associated fevers in metastatic melanoma causing extreme elevation in procalcitonin in the absence of infectionTimothy D Clay, Samantha E BowyerAsia-Pacific Journal of Clinical Oncology|December 16, 2025
Prolonged Survival in Anaplastic Thyroid Cancer: Insights From Multi-Modal TreatmentBella Nguyen, Richard Gauci, Connull Leslie, et al.Pathology|August 27, 2015
FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitorConnull Leslie, Samantha E Bowyer, Alison White, et al.Journal of the American Academy of Dermatology|November 30, 2025
Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort studyCatherine Bennett, Luke S McLean, Annette M Lim, et al.Melanoma Research|June 17, 2014
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanomaSamantha E Bowyer, Aparna D Rao, Megan Lyle, et al.Scientific Reports|July 29, 2021
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitorsSarah J Dart, Alistair M Cook, Michael J Millward, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket TrialPetros Grivas, Elena Garralda, Funda Meric-Bernstam, et al.The New England Journal of Medicine|June 2, 2025
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell CarcinomaDanny Rischin, Sandro Porceddu, Fiona Day, et al.Pageof 1